{"id":1428,"date":"2026-04-28T12:33:29","date_gmt":"2026-04-28T10:33:29","guid":{"rendered":"https:\/\/epilogy.org\/?p=1428"},"modified":"2026-04-28T12:50:53","modified_gmt":"2026-04-28T10:50:53","slug":"ispe-2026-annual-meeting","status":"publish","type":"post","link":"https:\/\/epilogy.org\/fr\/ispe-2026-annual-meeting","title":{"rendered":"ISPE 2026 Annual Meeting : deux communications orales pour l\u2019\u00e9quipe Epilogy \u00e0 Milan"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"1428\" class=\"elementor elementor-1428\">\n\t\t\t\t<div class=\"elementor-element elementor-element-52fa3a4 e-flex e-con-boxed e-con e-parent\" data-id=\"52fa3a4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0ddd13f elementor-widget elementor-widget-html\" data-id=\"0ddd13f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<style>\n.epilogy-news{\nbackground:#ffffff;\nborder:1px solid #ead3ee;\nborder-radius:8px;\npadding:24px;\nmargin:24px 0;\nfont-size:13px;\ncolor:#54595F;\nline-height:1.7;\nbox-shadow:0 2px 8px rgba(0,0,0,0.04);\n}\n\n.epilogy-news-header{\ndisplay:grid;\ngrid-template-columns:110px 1fr;\ngap:18px;\nalign-items:center;\npadding-bottom:18px;\nmargin-bottom:18px;\n}\n\n.epilogy-news-header img{\nwidth:110px;\nheight:110px;\nobject-fit:cover;\nborder-radius:100%;\ntransition:all .2s ease;\n}\n\n.epilogy-news-header img:hover{\ntransform:scale(1.03);\n}\n\n.epilogy-news-title{\nfont-size:22px;\nline-height:1.3;\nfont-weight:700;\ncolor:#7C2A86;\nmargin:0 0 8px 0;\n}\n\n.epilogy-news-subtitle{\nfont-size:13px;\ncolor:#777;\nmargin:0;\n}\n\n.epilogy-news-content{\nmargin:0 0 18px 0;\n}\n\n.epilogy-news-content p{\nmargin:0 0 14px 0;\n}\n\n.epilogy-news-content p:last-child{\nmargin-bottom:0;\n}\n\n.epilogy-news-highlight{\nbackground:#FADFFF;\npadding:16px;\nborder-radius:6px;\nmargin:20px 0;\nborder-left:4px solid #7C2A86;\ndisplay:grid;\ngrid-template-columns:90px 1fr;\ngap:14px;\nalign-items:center;\n}\n\n.epilogy-news-highlight img{\nwidth:90px;\nheight:90px;\nobject-fit:cover;\nborder-radius:100%;\n}\n\n.epilogy-news-highlight strong{\ncolor:#7C2A86;\n}\n\n.epilogy-news-button-wrap{\ntext-align:center;\nmargin-top:16px;\n}\n\n.epilogy-news-button{\ndisplay:inline-block;\nbackground:#7C2A86;\ncolor:#ffffff !important;\ntext-decoration:none;\npadding:10px 18px;\nborder-radius:30px;\nfont-size:12px;\nfont-weight:600;\ntransition:all .2s ease;\n}\n\n.epilogy-news-button:hover{\nopacity:.9;\ntransform:translateY(-1px);\n}\n\n@media(max-width:680px){\n\n.epilogy-news-header{\ngrid-template-columns:1fr;\ntext-align:center;\n}\n\n.epilogy-news-header img{\nmargin:0 auto;\n}\n\n.epilogy-news-highlight{\ngrid-template-columns:1fr;\ntext-align:center;\n}\n\n.epilogy-news-highlight img{\nmargin:0 auto;\n}\n\n}\n<\/style>\n\n<div class=\"epilogy-news\">\n\n<div class=\"epilogy-news-header\">\n<img decoding=\"async\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/04\/ispe_logo.jpg\" alt=\"ISPE\">\n\n<div>\n<h2 class=\"epilogy-news-title\">ISPE 2026 Annual Meeting : deux communications orales pour Mounya et Laetitia<\/h2>\n<p class=\"epilogy-news-subtitle\">Reconnaissance de l\u2019excellence scientifique en pharmaco-\u00e9pid\u00e9miologie<\/p>\n<\/div>\n<\/div>\n\n<div class=\"epilogy-news-content\">\n\n<p>\nL\u2019\u00e9dition 2026 du congr\u00e8s annuel de International Society for Pharmacoepidemiology (ISPE) se tiendra \u00e0 Milan du 31 ao\u00fbt au 2 septembre 2026 autour du th\u00e8me : Lib\u00e9rer le potentiel de la pharmaco-\u00e9pid\u00e9miologie pour am\u00e9liorer la sant\u00e9 des patients. Cet \u00e9v\u00e9nement international de r\u00e9f\u00e9rence r\u00e9unira chercheurs, cliniciens, m\u00e9thodologistes, autorit\u00e9s r\u00e9glementaires et experts du monde entier autour des enjeux majeurs de la pharmaco-\u00e9pid\u00e9miologie moderne.\n<\/p>\n\n<p>\nDans un contexte marqu\u00e9 par l\u2019essor massif des donn\u00e9es de sant\u00e9 et du real-world evidence (RWE), le congr\u00e8s abordera les d\u00e9fis li\u00e9s \u00e0 la production de donn\u00e9es robustes et \u00e0 leur utilisation pour am\u00e9liorer la d\u00e9cision clinique, la r\u00e9gulation du m\u00e9dicament, la gestion des risques, la communication en sant\u00e9 et les politiques publiques. Le programme comprendra conf\u00e9rences pl\u00e9ni\u00e8res, ateliers, symposiums et sessions scientifiques favorisant les \u00e9changes interdisciplinaires et les collaborations internationales.\n<\/p>\n\n<p>\n\u00c0 cette occasion, l\u2019\u00e9quipe Epilogy sera mise \u00e0 l\u2019honneur avec l\u2019acceptation de deux abstracts en communications orales :\n<\/p>\n\n<\/div>\n\n<div class=\"epilogy-news-highlight\">\n\n<img decoding=\"async\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/Mounya-Abboud-min.png\" alt=\"Mounya Abboud\">\n\n<div>\n<strong>Mounya Abboud<\/strong><br>\nRisque de zona parmi les patients atteints de maladies inflammatoires \u00e0 m\u00e9diation immunitaire initiant des bioth\u00e9rapies ou des traitements synth\u00e9tiques cibl\u00e9s : une \u00e9tude de cohorte nationale\n<\/div>\n\n<\/div>\n\n<div class=\"epilogy-news-highlight\">\n\n<img decoding=\"async\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/laietitia-penso-min.png\" alt=\"Laetitia Penso\">\n\n<div>\n<strong>Laetitia Penso<\/strong><br>\nRisque d\u2019\u00e9v\u00e9nements cardiovasculaires majeurs (MACE) chez les patients atteints de psoriasis, de rhumatisme psoriasique et\/ou d\u2019autres formes de spondyloarthrite : une cohorte de 72 291 nouveaux utilisateurs de bioth\u00e9rapies\n<\/div>\n\n<\/div>\n\n<div class=\"epilogy-news-content\">\n\n<p>\nCette double s\u00e9lection souligne la qualit\u00e9 scientifique des travaux men\u00e9s par l\u2019\u00e9quipe Epilogy et son implication croissante dans la recherche internationale en pharmaco\u00e9pid\u00e9miologie, notamment dans l\u2019\u00e9valuation de la s\u00e9curit\u00e9 des traitements et des comorbidit\u00e9s associ\u00e9es aux maladies inflammatoires chroniques. F\u00e9licitations Mounya et Laetitia!\n<\/p>\n\n<\/div>\n\n<div class=\"epilogy-news-button-wrap\">\n<a href=\"https:\/\/www.pharmacoepi.org\/meetings\/annual-conference\/\" target=\"_blank\" class=\"epilogy-news-button\">\nVisitez le site de l'ISPE\n<\/a>\n<\/div>\n\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>ISPE 2026 Annual Meeting \u2013 Two Oral Presentations for Mounya and Laetitia Recognition for scientific excellence in pharmacoepidemiology The International Society for Pharmacoepidemiology 2026 Annual Meeting will take place in Milan from August 31 to September 2, 2026, under the theme Unlocking the Power of Pharmacoepidemiology to Improve Patient Health. This leading international event will&hellip;&nbsp;<a href=\"https:\/\/epilogy.org\/fr\/ispe-2026-annual-meeting\" rel=\"bookmark\"><span class=\"screen-reader-text\">ISPE 2026 Annual Meeting : deux communications orales pour l\u2019\u00e9quipe Epilogy \u00e0 Milan<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","footnotes":""},"categories":[19,1,18],"tags":[],"class_list":["post-1428","post","type-post","status-publish","format-standard","hentry","category-epifocus","category-epilogy","category-epinews"],"_links":{"self":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/comments?post=1428"}],"version-history":[{"count":7,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1428\/revisions"}],"predecessor-version":[{"id":1439,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1428\/revisions\/1439"}],"wp:attachment":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/media?parent=1428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/categories?post=1428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/tags?post=1428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}